 Samuel Gubbels
Concepts (357)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 8 | 2023 | 93 | 3.370 |
Why?
| | Cochlear Implantation | 8 | 2023 | 79 | 2.900 |
Why?
| | Neuroma, Acoustic | 7 | 2022 | 32 | 2.410 |
Why?
| | Hearing Loss | 7 | 2022 | 183 | 2.210 |
Why?
| | Cochlea | 9 | 2023 | 90 | 1.930 |
Why?
| | Hearing | 8 | 2023 | 131 | 1.580 |
Why?
| | Semicircular Canals | 4 | 2021 | 28 | 1.470 |
Why?
| | Speech Perception | 5 | 2022 | 73 | 1.390 |
Why?
| | Otitis Media | 7 | 2022 | 142 | 1.120 |
Why?
| | Radiosurgery | 3 | 2019 | 299 | 1.110 |
Why?
| | Deafness | 5 | 2023 | 77 | 1.070 |
Why?
| | Ear, Inner | 5 | 2020 | 39 | 1.040 |
Why?
| | Nestin | 2 | 2016 | 16 | 1.030 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 21 | 0.940 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.880 |
Why?
| | Gentamicins | 1 | 2023 | 42 | 0.850 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 44 | 0.840 |
Why?
| | Endoscopy | 3 | 2020 | 245 | 0.770 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 10 | 0.770 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 18 | 0.750 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 13 | 0.730 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 64 | 0.710 |
Why?
| | Otolaryngologists | 1 | 2020 | 10 | 0.700 |
Why?
| | Hair Cells, Auditory | 4 | 2021 | 39 | 0.680 |
Why?
| | Paraganglioma | 1 | 2020 | 46 | 0.660 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 24 | 0.650 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3039 | 0.640 |
Why?
| | Tinnitus | 3 | 2018 | 57 | 0.640 |
Why?
| | Audiometry, Pure-Tone | 4 | 2018 | 22 | 0.630 |
Why?
| | Ear Neoplasms | 1 | 2018 | 4 | 0.620 |
Why?
| | Vertigo | 3 | 2023 | 37 | 0.620 |
Why?
| | Eustachian Tube | 1 | 2018 | 4 | 0.620 |
Why?
| | Meningioma | 1 | 2019 | 76 | 0.610 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 54 | 0.610 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 86 | 0.610 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 56 | 0.590 |
Why?
| | Hearing Aids | 2 | 2016 | 63 | 0.570 |
Why?
| | Radiation Injuries | 1 | 2018 | 128 | 0.570 |
Why?
| | Physicians' Offices | 1 | 2016 | 16 | 0.540 |
Why?
| | Membrane Proteins | 2 | 2020 | 1016 | 0.540 |
Why?
| | Humans | 59 | 2023 | 114045 | 0.530 |
Why?
| | Surgical Flaps | 2 | 2016 | 121 | 0.530 |
Why?
| | Sex Characteristics | 1 | 2021 | 636 | 0.530 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 427 | 0.510 |
Why?
| | Suture Anchors | 1 | 2016 | 31 | 0.510 |
Why?
| | Skin Transplantation | 1 | 2016 | 57 | 0.500 |
Why?
| | Cell Differentiation | 2 | 2021 | 1696 | 0.490 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2272 | 0.480 |
Why?
| | Device Removal | 1 | 2016 | 123 | 0.480 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 7 | 0.470 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 4 | 0.470 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 63 | 0.470 |
Why?
| | Blood | 1 | 2014 | 94 | 0.460 |
Why?
| | Hyperacusis | 1 | 2014 | 9 | 0.450 |
Why?
| | Cholesteatoma | 1 | 2014 | 11 | 0.440 |
Why?
| | Temporal Bone | 5 | 2017 | 44 | 0.420 |
Why?
| | Jugular Veins | 1 | 2013 | 38 | 0.420 |
Why?
| | Patient Selection | 1 | 2016 | 629 | 0.420 |
Why?
| | Bacteremia | 1 | 2014 | 160 | 0.420 |
Why?
| | Mutation | 2 | 2020 | 3338 | 0.420 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.410 |
Why?
| | Polyvinyls | 1 | 2012 | 17 | 0.410 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 684 | 0.410 |
Why?
| | Influenza B virus | 1 | 2012 | 34 | 0.400 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 36 | 0.400 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 42 | 0.400 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 13 | 0.400 |
Why?
| | Melanoma | 1 | 2018 | 620 | 0.400 |
Why?
| | Influenza A virus | 1 | 2012 | 90 | 0.390 |
Why?
| | Denmark | 5 | 2016 | 39 | 0.380 |
Why?
| | Stapes Surgery | 2 | 2023 | 13 | 0.380 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 527 | 0.370 |
Why?
| | Middle Aged | 19 | 2022 | 26605 | 0.370 |
Why?
| | Aging | 2 | 2021 | 1611 | 0.360 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 138 | 0.360 |
Why?
| | Artifacts | 2 | 2023 | 114 | 0.360 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 178 | 0.360 |
Why?
| | Female | 25 | 2023 | 59324 | 0.350 |
Why?
| | Otologic Surgical Procedures | 4 | 2021 | 16 | 0.350 |
Why?
| | Fucosyltransferases | 2 | 2022 | 27 | 0.350 |
Why?
| | Laser Therapy | 2 | 2023 | 99 | 0.350 |
Why?
| | Male | 28 | 2022 | 55396 | 0.340 |
Why?
| | Genetic Therapy | 5 | 2020 | 256 | 0.340 |
Why?
| | Retrospective Studies | 14 | 2022 | 12521 | 0.330 |
Why?
| | Transfection | 2 | 2009 | 863 | 0.330 |
Why?
| | Adult | 20 | 2023 | 30375 | 0.320 |
Why?
| | Bacteria | 1 | 2014 | 725 | 0.310 |
Why?
| | Intensive Care Units | 1 | 2012 | 614 | 0.300 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 5 | 0.300 |
Why?
| | Encephalocele | 1 | 2007 | 6 | 0.300 |
Why?
| | Nasopharynx | 2 | 2022 | 61 | 0.290 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 131 | 0.290 |
Why?
| | Animals | 16 | 2023 | 31565 | 0.280 |
Why?
| | Uterus | 1 | 2008 | 191 | 0.280 |
Why?
| | Cross Infection | 2 | 2022 | 194 | 0.280 |
Why?
| | Neurons | 1 | 2015 | 1277 | 0.280 |
Why?
| | Hearing Tests | 2 | 2020 | 49 | 0.280 |
Why?
| | Influenza, Human | 1 | 2012 | 543 | 0.270 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 225 | 0.270 |
Why?
| | Tracheal Diseases | 1 | 2006 | 13 | 0.260 |
Why?
| | Mice | 10 | 2023 | 14843 | 0.260 |
Why?
| | Bioprosthesis | 1 | 2006 | 36 | 0.260 |
Why?
| | Aged | 13 | 2022 | 18969 | 0.240 |
Why?
| | Incidence | 5 | 2016 | 2314 | 0.230 |
Why?
| | Treatment Outcome | 9 | 2022 | 9049 | 0.230 |
Why?
| | Trachea | 1 | 2006 | 223 | 0.230 |
Why?
| | Airway Obstruction | 1 | 2006 | 160 | 0.230 |
Why?
| | Audiometry | 2 | 2014 | 26 | 0.220 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 13 | 0.220 |
Why?
| | Cadaver | 5 | 2023 | 298 | 0.210 |
Why?
| | Penicillins | 1 | 2023 | 52 | 0.210 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 41 | 0.210 |
Why?
| | Synapses | 2 | 2021 | 331 | 0.210 |
Why?
| | Meniere Disease | 1 | 2023 | 30 | 0.200 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 4 | 0.200 |
Why?
| | Aged, 80 and over | 6 | 2016 | 6306 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2022 | 28 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 82 | 0.190 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 148 | 0.190 |
Why?
| | Microsurgery | 2 | 2020 | 58 | 0.190 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 532 | 0.190 |
Why?
| | Otolithic Membrane | 1 | 2021 | 4 | 0.190 |
Why?
| | Labyrinthitis | 1 | 2021 | 2 | 0.190 |
Why?
| | Neurons, Efferent | 1 | 2021 | 7 | 0.190 |
Why?
| | Vestibular Nerve | 1 | 2021 | 16 | 0.180 |
Why?
| | Vestibular Diseases | 1 | 2021 | 22 | 0.180 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 474 | 0.180 |
Why?
| | Mice, Transgenic | 2 | 2016 | 1947 | 0.180 |
Why?
| | Scoliosis | 1 | 2023 | 178 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 29 | 0.180 |
Why?
| | Noise | 1 | 2021 | 66 | 0.170 |
Why?
| | Ear, Middle | 4 | 2022 | 89 | 0.170 |
Why?
| | Hypersensitivity | 1 | 2023 | 252 | 0.170 |
Why?
| | Microbiota | 3 | 2022 | 648 | 0.170 |
Why?
| | Magnets | 1 | 2019 | 15 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2020 | 294 | 0.150 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 8 | 0.150 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 4680 | 0.150 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 16 | 0.150 |
Why?
| | Mucous Membrane | 1 | 2018 | 108 | 0.150 |
Why?
| | Infant | 7 | 2019 | 7943 | 0.140 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 94 | 0.140 |
Why?
| | Hospitals | 3 | 2022 | 581 | 0.140 |
Why?
| | Genetic Testing | 1 | 2020 | 381 | 0.140 |
Why?
| | Surgical Equipment | 1 | 2017 | 13 | 0.140 |
Why?
| | Neurotology | 1 | 2017 | 1 | 0.140 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 21 | 0.140 |
Why?
| | Adolescent | 8 | 2023 | 17800 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 370 | 0.140 |
Why?
| | Child, Preschool | 7 | 2019 | 9114 | 0.140 |
Why?
| | Regeneration | 1 | 2018 | 158 | 0.140 |
Why?
| | Dissection | 1 | 2017 | 51 | 0.140 |
Why?
| | Patient Positioning | 1 | 2017 | 41 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 594 | 0.140 |
Why?
| | Age Factors | 3 | 2012 | 2885 | 0.130 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1331 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 722 | 0.130 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 91 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 164 | 0.130 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 7 | 0.130 |
Why?
| | Child | 9 | 2023 | 18401 | 0.130 |
Why?
| | Quality of Life | 3 | 2023 | 2343 | 0.130 |
Why?
| | Organogenesis | 1 | 2016 | 55 | 0.130 |
Why?
| | Automation | 1 | 2016 | 74 | 0.130 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 46 | 0.130 |
Why?
| | Scalp | 1 | 2016 | 29 | 0.130 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.120 |
Why?
| | Ifosfamide | 1 | 2015 | 32 | 0.120 |
Why?
| | Educational Measurement | 1 | 2017 | 235 | 0.120 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 39 | 0.120 |
Why?
| | Durapatite | 2 | 2021 | 35 | 0.120 |
Why?
| | Young Adult | 6 | 2019 | 10444 | 0.120 |
Why?
| | Etoposide | 1 | 2015 | 149 | 0.120 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 102 | 0.120 |
Why?
| | Audiology | 1 | 2014 | 17 | 0.120 |
Why?
| | Animals, Newborn | 1 | 2016 | 777 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 460 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2017 | 2764 | 0.110 |
Why?
| | Tamoxifen | 1 | 2015 | 190 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1471 | 0.110 |
Why?
| | Luminescent Proteins | 1 | 2015 | 166 | 0.110 |
Why?
| | Methotrexate | 1 | 2015 | 227 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 868 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2010 | 4392 | 0.110 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 10 | 0.110 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 6 | 0.110 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 49 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1518 | 0.100 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 10 | 0.100 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 6 | 0.100 |
Why?
| | Disease Progression | 1 | 2019 | 2371 | 0.100 |
Why?
| | Phenotype | 1 | 2020 | 2784 | 0.100 |
Why?
| | Seasons | 1 | 2014 | 440 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 582 | 0.100 |
Why?
| | Disease Notification | 1 | 2012 | 12 | 0.100 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 10 | 0.100 |
Why?
| | Meat Products | 1 | 2012 | 25 | 0.100 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 371 | 0.100 |
Why?
| | Food Contamination | 1 | 2012 | 43 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2013 | 90 | 0.100 |
Why?
| | Vestibule, Labyrinth | 1 | 2012 | 54 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1791 | 0.100 |
Why?
| | Sex Factors | 2 | 2014 | 1706 | 0.100 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.090 |
Why?
| | Foodborne Diseases | 1 | 2012 | 44 | 0.090 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 803 | 0.090 |
Why?
| | Age Distribution | 1 | 2012 | 341 | 0.090 |
Why?
| | Sex Distribution | 1 | 2012 | 336 | 0.090 |
Why?
| | Viral Tropism | 1 | 2011 | 24 | 0.090 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 150 | 0.090 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 8 | 0.090 |
Why?
| | Skull Base | 2 | 2021 | 39 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1690 | 0.090 |
Why?
| | Ear Canal | 1 | 2011 | 14 | 0.090 |
Why?
| | Dependovirus | 1 | 2011 | 52 | 0.090 |
Why?
| | Ganglion Cysts | 1 | 2011 | 9 | 0.090 |
Why?
| | Lasers | 2 | 2023 | 121 | 0.090 |
Why?
| | Ear Diseases | 1 | 2011 | 13 | 0.090 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 6 | 0.090 |
Why?
| | Zygoma | 1 | 2010 | 11 | 0.090 |
Why?
| | Clinical Competence | 1 | 2017 | 882 | 0.090 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 165 | 0.090 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 221 | 0.090 |
Why?
| | Adenoviridae | 1 | 2011 | 184 | 0.090 |
Why?
| | Cost of Illness | 1 | 2012 | 254 | 0.090 |
Why?
| | Electroencephalography | 1 | 2012 | 359 | 0.090 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 147 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2322 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2011 | 287 | 0.080 |
Why?
| | Prospective Studies | 3 | 2012 | 6195 | 0.080 |
Why?
| | Abscess | 1 | 2010 | 70 | 0.080 |
Why?
| | Disease Outbreaks | 1 | 2012 | 305 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2173 | 0.080 |
Why?
| | Comorbidity | 1 | 2014 | 1447 | 0.080 |
Why?
| | Maxilla | 1 | 2009 | 29 | 0.080 |
Why?
| | Population Surveillance | 1 | 2012 | 385 | 0.080 |
Why?
| | Skull Fractures | 1 | 2009 | 28 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 610 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 511 | 0.080 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 10 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 662 | 0.080 |
Why?
| | Electroporation | 1 | 2009 | 31 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2008 | 3498 | 0.080 |
Why?
| | Electric Conductivity | 1 | 2008 | 88 | 0.080 |
Why?
| | Dyneins | 1 | 2008 | 29 | 0.080 |
Why?
| | Cleft Lip | 1 | 2008 | 31 | 0.080 |
Why?
| | Swine | 2 | 2012 | 687 | 0.080 |
Why?
| | Myosins | 1 | 2008 | 125 | 0.070 |
Why?
| | Cleft Palate | 1 | 2008 | 49 | 0.070 |
Why?
| | Chronic Disease | 1 | 2014 | 1577 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 920 | 0.070 |
Why?
| | Bone Cements | 1 | 2007 | 35 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 97 | 0.070 |
Why?
| | Craniotomy | 1 | 2007 | 68 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1356 | 0.070 |
Why?
| | Biomarkers | 1 | 2016 | 3397 | 0.070 |
Why?
| | Prevalence | 1 | 2012 | 2247 | 0.070 |
Why?
| | Postoperative Care | 1 | 2007 | 223 | 0.070 |
Why?
| | Neck Dissection | 1 | 2005 | 10 | 0.060 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 7 | 0.060 |
Why?
| | Random Allocation | 1 | 2006 | 328 | 0.060 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 80 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 121 | 0.060 |
Why?
| | Neck | 1 | 2005 | 85 | 0.060 |
Why?
| | Rabbits | 1 | 2006 | 733 | 0.060 |
Why?
| | Biopsy | 2 | 2011 | 1024 | 0.060 |
Why?
| | Postoperative Complications | 2 | 2021 | 2122 | 0.060 |
Why?
| | Models, Animal | 1 | 2006 | 340 | 0.060 |
Why?
| | Safety | 1 | 2006 | 298 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2014 | 5038 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2007 | 372 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2012 | 3003 | 0.060 |
Why?
| | Hearing Disorders | 1 | 2003 | 9 | 0.050 |
Why?
| | Hospitalization | 1 | 2012 | 1762 | 0.050 |
Why?
| | Algorithms | 3 | 2017 | 1469 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 33 | 0.050 |
Why?
| | Eye Diseases | 1 | 2003 | 74 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 126 | 0.050 |
Why?
| | Hydroxyapatites | 1 | 2021 | 12 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 48 | 0.050 |
Why?
| | Esthetics | 1 | 2021 | 37 | 0.050 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.050 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.050 |
Why?
| | Facial Nerve | 1 | 2021 | 30 | 0.050 |
Why?
| | Auditory Threshold | 2 | 2011 | 36 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 577 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 4595 | 0.040 |
Why?
| | Infection Control | 1 | 2022 | 132 | 0.040 |
Why?
| | Nose | 1 | 2020 | 55 | 0.040 |
Why?
| | Scala Tympani | 1 | 2020 | 9 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 5499 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 493 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2021 | 181 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 485 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 69 | 0.040 |
Why?
| | Finland | 1 | 2019 | 69 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 188 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2018 | 25 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 175 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 735 | 0.040 |
Why?
| | Incus | 1 | 2017 | 8 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 91 | 0.040 |
Why?
| | Ear Ossicles | 1 | 2017 | 15 | 0.040 |
Why?
| | Exome | 1 | 2018 | 200 | 0.040 |
Why?
| | Stapes | 1 | 2017 | 31 | 0.040 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 47 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 388 | 0.030 |
Why?
| | Forecasting | 1 | 2018 | 331 | 0.030 |
Why?
| | Pressure | 1 | 2017 | 214 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 590 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 384 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 631 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 850 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 295 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 1875 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 828 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 5 | 0.030 |
Why?
| | Time | 1 | 2014 | 70 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1880 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2629 | 0.030 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 1 | 0.030 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.030 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 17 | 0.030 |
Why?
| | Cues | 1 | 2014 | 301 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 38 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 76 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2090 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 113 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 47 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 196 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 306 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 945 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 393 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 318 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 108 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1144 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 761 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 813 | 0.020 |
Why?
| | Probability | 1 | 2008 | 286 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 541 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4501 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 431 | 0.020 |
Why?
| | Fluorouracil | 1 | 2005 | 152 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 275 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 332 | 0.010 |
Why?
| | Cisplatin | 1 | 2005 | 262 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 513 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 801 | 0.010 |
Why?
| | United States | 1 | 2019 | 12137 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 949 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 2958 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6077 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|